Humacyte (HUMA) Stock Price, Quote, News & History | Benzinga

Humacyte (HUMA) Stock Price, Quote, News & History

HUMANASDAQ

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$1.00

-0.03-2.91%

At close: Jan 27, 4:00 PM EST

$1.02

-0.005-0.49%

Pre-Market: 7:00 AM EST

Overview

News Earnings Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

-

Close

$1.00

Volume / Avg.

3.26K / 4.89M

Day Range

- - -

52 Wk Range

0.91 - 4.85

Market Cap

$191.95M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

21.79%

Days to Cover

6.47

Recent Humacyte Inc News

Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback

Small-cap benchmark Russell 2000 ETF hits record high after Fed cuts rates, hinting at more cuts. Small caps rally 43% since tariff-driven selloff.

Piero Cingari

GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Gold Falls 1%; ProKidney Shares Spike Higher

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-105.50M

Investing Cash Flow (TTM)

-908.00K

Financing Cash Flow (TTM)

55.32M

Free Cash Flow (TTM)

-106.40M

Capital Expenditure (TTM)

-908.00K

Net Change in Cash (TTM)

-51.08M

Analyst Trends and Forecast

2

Oct 25

6

Nov 25

1

Dec 25

3

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$203.28M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

91.09

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-27.01%

Earnings Yield % (FWD)

-51.02%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.02

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$2.83M

Total Cash

$19.49M

Debt to Equity

-

Issuance of Debt (TTM)

-$2.83M

Repayment of Debt (TTM)

-$2.83M

Key Statistics

Open

-

Close

$1.00

Volume / Avg.

3.26K / 4.89M

Day Range

- - -

52 Wk Range

0.91 - 4.85

Market Cap

$191.95M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

21.79%

Days to Cover

6.47

About

Sector

Health Care

Industry

Biotechnology

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures ac...

Show More

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Humacyte (HUMA) stock?

A

You can purchase shares of Humacyte (NASDAQ:HUMA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Humacyte (HUMA) competitors?

A

Other companies in Humacyte’s space includes: Kalaris Therapeutics Inc (NASDAQ:KLRS), Innate Pharma SA (NASDAQ:IPHA), Tharimmune Inc (NASDAQ:THAR), Galectin Therapeutics Inc (NASDAQ:GALT) and ProQR Therapeutics NV (NASDAQ:PRQR).

Q

What is the forecast, or price target, for Humacyte (HUMA) stock?

A

Humacyte has a consensus price target of $10.42.

Q

What is the current price for Humacyte (HUMA)?

A

The stock price for Humacyte (NASDAQ: HUMA) is $1.025 last updated January 29, 2026 at 7:57 AM EST.

Q

Does Humacyte (HUMA) pay a dividend?

A

There are no upcoming dividends for Humacyte.

Q

When is Humacyte (NASDAQ:HUMA) reporting earnings?

A

Humacyte does not have any upcoming earnings scheduled.

Q

Is Humacyte (HUMA) going to split?

A

There is no upcoming split for Humacyte.

Q

What sector and industry does Humacyte (HUMA) operate in?

A

Humacyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Kalaris Therapeutics Inc

Innate Pharma SA

Galectin Therapeutics Inc

ProQR Therapeutics NV

Zentalis Pharmaceuticals Inc

Century Therapeutics Inc